A 28-year-old man presents with acute bacterial meningitis. CSF shows elevated protein, low glucose, and positive Gram stain (gram-positive cocci in pairs). What is the drug of choice for empiric treatment pending culture confirmation?

Explanation

## Drug of Choice for Acute Bacterial Meningitis ### Clinical Presentation & Microbiology The CSF findings (elevated protein, low glucose, gram-positive cocci in pairs) are consistent with **Streptococcus pneumoniae**, the most common cause of community-acquired bacterial meningitis in adults. Gram-positive diplococci are pathognomonic for pneumococcal meningitis. ### Why Ceftriaxone is First-Line **Key Point:** Ceftriaxone (or cefotaxime) is the drug of choice for empiric treatment of acute bacterial meningitis in adults because it achieves high CSF penetration, covers the most common pathogens (S. pneumoniae, N. meningitidis, L. monocytogenes in older adults), and has excellent bactericidal activity. **High-Yield:** Ceftriaxone 2 g IV 12-hourly (or 4 g/day in divided doses) is the standard empiric regimen for acute meningitis. It penetrates inflamed meninges well and covers both pneumococcal and meningococcal meningitis. **Clinical Pearl:** In India, ceftriaxone is the empiric first-line choice for acute meningitis. If Listeria monocytogenes is suspected (age >50 or immunocompromised), ampicillin or penicillin G should be added. Vancomycin is added if MRSP (methicillin-resistant S. pneumoniae) or penicillin resistance is suspected. ### Empiric Meningitis Regimen ```mermaid flowchart TD A[Acute bacterial meningitis suspected]:::outcome --> B{Age & risk factors?}:::decision B -->|18-50 years, immunocompetent| C[Ceftriaxone 2g IV 12-hourly]:::action B -->|>50 years or immunocompromised| D[Ceftriaxone + Ampicillin]:::action B -->|Penicillin allergy| E[Fluoroquinolone or Chloramphenicol]:::action C --> F{Culture result?}:::decision D --> F F -->|S. pneumoniae| G[Continue ceftriaxone ± vancomycin if resistant]:::action F -->|N. meningitidis| H[Ceftriaxone or Penicillin G]:::action F -->|L. monocytogenes| I[Ampicillin or Penicillin G]:::action ``` ### Comparison with Other Options | Drug | Indication | Limitation | |------|-----------|----------| | **Ceftriaxone** | Empiric meningitis; S. pneumoniae, N. meningitidis | Add ampicillin if age >50 | | Chloramphenicol | Penicillin allergy; good CSF penetration | Rare (bone marrow toxicity); outdated | | Penicillin G | Meningococcal meningitis (if susceptible) | Does NOT cover all pneumococcal strains; poor for resistant pneumococci | | Meropenem | Resistant gram-negatives, Pseudomonas | Not first-line; reserved for resistant organisms or beta-lactam allergy | **Warning:** Penicillin G alone is NO LONGER recommended as monotherapy for empiric meningitis because of increasing pneumococcal resistance. Ceftriaxone is superior because it covers both susceptible and intermediate-resistant pneumococci. **Mnemonic:** **CAP** = **C**eftriaxone, **A**mpicillin (if age >50), **P**enicillin (for meningococcal if susceptible). Ceftriaxone is the backbone of empiric meningitis therapy. [cite:Harrison 21e Ch 149; Robbins 10e Ch 3]